LCTX
Lineage Cell Therapeutics Inc
0.971$
-5.7%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Lineage Cell Therapeutics Inc (LCTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39 | -45 | -42 | -31 | -31 | -32 | -20 | -24 | 1.1 | -29 | -23 | -19 | |
| 8.4 | 6.3 | 4.8 | 3.3 | 3.3 | 3.0 | 2.0 | 0.9 | 0.7 | 0.7 | 0.6 | 0.7 | |
| 4.5 | 11 | 8.0 | 3.9 | 5.4 | 3.6 | 2.2 | 3.5 | 4.3 | 4.6 | 5.1 | 4.8 | |
| -10 | -7.8 | -80 | -17 | -76 | -4.5 | -3.5 | 3.0 | 4.2 | – | – | – | |
| -0.8 | 3.3 | -0.7 | 2.5 | 0.6 | -2.0 | 1.4 | 21 | 19 | -11 | -8.8 | -4.1 | |
| 0.5 | 5.3 | 2.5 | 1.3 | 3.3 | 0.4 | 0.1 | 0.4 | 0.4 | 0.7 | 0.6 | 0.5 | |
| -1.0 | -7.4 | -11 | -10 | 12 | 17 | 13 | 9.7 | -46 | 46 | -2.3 | -13 | |
| – | – | – | 0.5 | 34 | 0.0 | 25 | 7.2 | – | 0.0 | – | – | |
| 63 | 50 | 33 | -0.9 | -0.2 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.5 | 0.3 | 1.6 | 0.2 | -0.3 | -0.1 | 25 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | |
| 64 | 65 | 33 | 55 | 5.8 | 0.6 | 30 | 37 | 1.6 | 6.4 | 36 | 27 | |
| 24 | 13 | -20 | 15 | -13 | -14 | 23 | 23 | -44 | 24 | 10 | -5.0 | |
| -39 | -50 | -45 | -32 | -34 | -32 | -20 | -24 | 0.6 | -29 | -24 | -19 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.